Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 7.678,16 kr., with a 24-hour trading volume of 16,6B kr.. The asset's market cap is 6,84T kr., after moving 0.85% in the last day.
Tokenized Eli Lilly And Co is trading at 7.750,76 kr., with a tokenized market cap of 300,73M kr. and a 24-hour trading volume of 9,62M kr.. The tokenized asset has moved -0.48% in the past 24 hours.